- Home
- / Supriya Lifescience
Supriya Lifescience
Stock Price
₹603.3
2024-10-29
Market Capitalization
₹51.1 B
2024-10-29
Revenue
₹6.8 B
FY, 2025
Supriya Lifescience Summary
Company Summary
- Overview
- Supriya Lifescience is a company that manufactures active pharmaceutical ingredients. It offers anti-histamine, anti-allergic, anti-asthmatic, decongestant, vitamin, and other therapeutic segments.
- Type
- Public
- Status
- Active
- Founded
- 1987
- HQ
- Mumbai, IN | view all locations
- Cybersecurity rating
Table of Contents
Key People
Krishna Raghunathan, Chief Financial Officer
Rajeev Kumar Jain, Chief Executive Officer
Shweta Shivdhari Singh, Company Secretary and Compliance Officer
LocationsView all
1 location detected
Mumbai, MH HQ
India
Sharma Industrial Estate, Walbhat Rd, Jay Prakash Nagar, Goregaon
Supriya Lifescience Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹2.1B
- Gross profit (Q3, 2026)
- ₹1.5B
- Net income (Q3, 2026)
- ₹496.8M
- Cash (Q2, 2026)
- ₹1.0B
- EBIT (Q3, 2026)
- ₹674.1M
- Enterprise value
- $50.1B